Baxter International (NYSE:BAX) and Ingen Technologies (OTCMKTS:IGNT) Head to Head Contrast

Baxter International (NYSE:BAX) and Ingen Technologies (OTCMKTS:IGNT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation.

Volatility & Risk

Baxter International has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, Ingen Technologies has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500.

Valuation & Earnings

This table compares Baxter International and Ingen Technologies”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24 billion	0.79	-$957.00 million	($1.85)	-9.33
Ingen Technologies	N/A	N/A	N/A	N/A	N/A

Ingen Technologies has lower revenue, but higher earnings than Baxter International.

Profitability

This table compares Baxter International and Ingen Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	15.65%	5.19%
Ingen Technologies	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings for Baxter International and Ingen Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	3	8	2	0	1.92
Ingen Technologies	0	0	0	0	0.00

Baxter International currently has a consensus target price of $19.80, suggesting a potential upside of 14.75%. Given Baxter International’s stronger consensus rating and higher probable upside, analysts clearly believe Baxter International is more favorable than Ingen Technologies.

Institutional and Insider Ownership

90.2% of Baxter International shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Baxter International beats Ingen Technologies on 9 of the 10 factors compared between the two stocks.

About Baxter International

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company’s products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

About Ingen Technologies

Ingen Technologies, Inc. engages in the research and development of home healthcare products for the respiratory industry in United States. It offers oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark names for patients suffering with chronic obstructive pulmonary disease. The company was founded in 1999 and is based in Riverside, California.